GMP and GCP are not new concepts, however, recent developments in legislation have narrowed the interface between the two areas: GMP is now mandatory throughout the clinical trial process and GCP has been introduced to the Qualified Person’s responsibilities. Any misunderstanding of the regulations can lead to serious penalties and high costs. However, smooth and efficient running of a clinical study will result in the ultimate goal of a clinical trial: a marketing authorisation for your IMP.

The current economic situation highlights the need to ensure that this process is smooth and efficient; extra costs or recalls are unnecessary expenses which full knowledge of this area can mitigate.

VIBpharma’s GMP and GCP Compliance for Investigational Products will cover the critical challenges you are facing in this area. From clarifying the interface between GMP and GCP and a greater understanding of the rules and regulations, to practical hands-on experience in packaging and labelling, transport and distribution and the demands of a global market, this event is not to be missed.

This educational two-day conference, tailored to maximise the sharing of knowledge and expertise and to promote networking for professionals in this area, will ensure you meet the mandatory guidelines and legislative requirements to manufacture and monitor IPs in a timely and cost efficient manner.

Password: